share_log

Sera Prognostics | 4: Statement of changes in beneficial ownership of securities-Officer Boniface John J.

SEC announcement ·  Mar 27 05:40
Summary by Futu AI
John J. Boniface, the Chief Scientific Officer of Sera Prognostics, executed a sale of 21,438 shares of the company's common stock on March 26, 2024. The transaction was carried out in the open market with the shares sold at a price of $9.55 each. Following the sale, Boniface's direct holdings in Sera Prognostics amount to 143,524 shares. The total market value of the disposed shares is approximately $204,732.90. The transaction is currently reported as in progress.
John J. Boniface, the Chief Scientific Officer of Sera Prognostics, executed a sale of 21,438 shares of the company's common stock on March 26, 2024. The transaction was carried out in the open market with the shares sold at a price of $9.55 each. Following the sale, Boniface's direct holdings in Sera Prognostics amount to 143,524 shares. The total market value of the disposed shares is approximately $204,732.90. The transaction is currently reported as in progress.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.